Dhtml Menu Css by v5.7


The nanoemulsion was developed at the University of Michigan and was then moved to a Biotech Company, NanoBio Corp, Ann Arbor, MI, for further development of applications and commercialization.  One dermatologic application of nanoemulsion resulted in a successful treatment for Herpes Labialis, which are cold sores or fever blisters on the lips or surrounding skin that are predominantly caused by the Herpes simplex I (HSV1) virus. 

NanoBio Corp. took the product development through Phase IIa & b trials.  Next Phase results of this Herpes Labialis product will be published in October 2008.



Another application under development is an anti-infective for Genital Herpes, lesions of the genital area classically associated with Herpes simplex virus, type II (HSV-2).




© The Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS)® 2010
MNIMBS is a registered trademark of The Michigan Nanotechnology Institute for Medicine and Biological Sciences.
MNIMBS logo and graphic designed by Paul D. Trombley, website by Mellon & Associates, LLC
All other company, brand, and product names are or may be trademarks of their respective holders.